Richmond Pharmacology is pleased to announce our attendance at ESC Congress 2025, the European Society of Cardiology’s flagship event, held in Madrid from 29th August– 1st September.
Representing Richmond Pharmacology at ESC Congress:
• Dr Jörg Täubel, Chief Executive Officer
Dr Täubel looks forward to connecting with clinicians, researchers, and industry leaders, sharing Richmond’s expertise in:
• Early-phase cardiovascular and cardiometabolic trials
• Novel endpoints and digital health integration
• Risk-stratified study design and cardiac safety
• Accelerated CV drug development pathways
• Patient-focused recruitment and retention
If you’re attending ESC 2025 and seeking an expert partner for cardiovascular clinical trials, we welcome meeting requests at: info@richmondpharmacology.com
.svg){kind=small}
-min.jpg)
.jpg)
